Table 3.

Univariate survival analysis of RASGRF1 expression in subgroups with different clinical parameters.

			PFS		OS
			Hazard Ratio		Hazard Ratio
Clinical parameters		n	(95%CI)	P Value	(95%CI)	P Value
Age(years)
	<65	152	0.339(0.219∼0.524)	<0.0001***	0.361(0.212∼0.616)	0.0015**
	≥65	64	0.856(0.417∼1.759)	0.6825	0.809(0.345∼1.897)	0.6372
Gender
	Males	118	0.475(0.286∼0.791)	0.0152*	0.419(0.233∼0.755)	0.0185*
	Females	98	0.430(0.247∼0.749)	0.0053**	0.550(0.270∼1.120)	0.1189
Type
	LUAD	177	0.445(0.299∼0.664)	0.0003***	0.488(0.295∼0.806)	0.0108*
	LUSC	39	0.257(0.081∼0.813)	0.1468	0.331(0.093∼1.174)	0.2486
Clinical stage
	I+II	147	0.420(0.253∼0.696)	0.003**	0.385(0.198∼0.748)	0.0174*
	III	69	0.572(0.329∼0.997)	0.0743	0.571(0.310∼1.054)	0.1053
T classification
	T1	97	0.436(0.237∼0.799)	0.0141*	0.388(0.181∼0.832)	0.033*
	T2+T3+T4	119	0.503(0.313∼0.809)	0.0133*	0.549(0.312∼0.966)	0.0679
N classification
	N0	136	0.404(0.238∼0.685)	0.0028**	0.402(0.201∼0.867)	0.0264*
	N1+N2+N3	80	0.637(0.370∼1.096)	0.1365	0.617(0.336∼1.135)	0.1609
Smoke
	No smoking	112	0.427(0.260∼0.704)	0.0019**	0.565(0.294∼1.083)	0.1054
	Smoking	104	0.450(0.255∼0.793)	0.022*	0.367(0.195∼0.691)	0.0156*

Note. Bold font indicates P < 0.05.